The investigators determined which antibody was best able to specifically bind the fusion protein. They used this antibody to compare the amounts of freestanding BTLA and HVEM and their protein ...

IBI3014 is a bispecific ADC targeting TROP2 and PD-L1. Its dual mechanism integrates TROP2-directed tumor killing with PD-L1 ...

The investigators determined which antibody was best able to specifically bind the fusion protein. They used this antibody to compare the amounts of freestanding BTLA and HVEM and their protein ...

The investigators determined which antibody was best able to specifically bind the fusion protein. They used this antibody to compare the amounts of freestanding BTLA and HVEM and their protein ...

The Gator instrument helps quantify the interference pattern caused by variations in the amount of protein limited ... 2000 μg/mL Yes Human Fc Immobilize human Fc-fusion protein or human IgG ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Belfast firm to partner with QUB to develop humanised therapeutic antibody to combat treatment-resistant cancers ...

Vera Therapeutics, Inc.’s VERA share price has surged by 6.17%, which has investors questioning if this is right time to sell.

Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these ...

In addition to working on traditional biopharmaceuticals, I have pioneered structural studies on emerging forms of protein therapeutics, such as bispecific antibodies, complex fusion proteins and ...